StockData
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. (HRMY) stock

HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.01+0.05 (+0.15%)

Close on Nov 17, 2026Market cap $1.92BP/E 10.7Yield –

Harmony Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Harmony Biosciences's enterprise value was $1.48B on Nov 11, 2026, against $1.53B a year earlier. Over the last 5 years it ranged from $1.01B to $3.43B, with a median of $1.74B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.48B-10.7%
2025Dec 31, 2025$1.65B-4.8%
2024Dec 31, 2024$1.73B+1.0%
2023Dec 29, 2023$1.72B-45.5%
2022Dec 30, 2022$3.15B+26.4%
2021Dec 31, 2021$2.49B+23.0%
2020Dec 31, 2020$2.03B–

More Harmony Biosciences figures

See a number that looks wrong?